Volume 2, Issue 1 (Spring & summer 2008)                   IJPBS 2008, 2(1): 54-59 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Noroozi A, Mianji F. Singapore's Experience With Buprenorphine (Subutex). IJPBS. 2008; 2 (1) :54-59
URL: http://ijpbs.mazums.ac.ir/article-1-132-en.html
Abstract:   (10153 Views)
Buprenorphine (Subutex) has been used to treat opioid dependency in the past 16 years. Subutex (or buprenorphine hydrochloride) was approved by the Singapore's Ministry of Health (MOH) in 2000 as a substitution treatment for opiate-dependent drug abusers within the framework of medical, social and psychological treatments. It was subsequently introduced into the Singapore market in 2002. In spite of the promise of improvement in the lives of addicts with medical care, a distinct trend of buprenorphine abuse has occurred. A cascade of events from 2002 to 2006 led to discontinuation of Subutex treatment programs in the country. In this paper, firstly reports on morbidity and mortality caused by Subutex IV abuse will be reviewed and secondly, the MOH response to the situation will be outlined and finally, implications of Singapore’s experience with Subutex will be discussed.
Full-Text [PDF 241 kb]   (1498 Downloads)    
Type of Study: Research | Subject: Psychiatry
Received: 2012/05/28 | Accepted: 2014/01/6 | Published: 2014/01/6

Add your comments about this article : Your username or Email:
Write the security code in the box

Send email to the article author

© 2015 All Rights Reserved | Iranian Journal of Psychiatry and Behavioral Sciences

Designed & Developed by : Yektaweb